Streetbeat News

Revenues

EQIX

Equinix (NASDAQ:EQIX) has significantly outperformed the market over the past 15 years, with an average annual return of 16.32%. A $1000 investment in EQIX 15 years ago would now be worth $9,640.41. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 5:30 pm

CMG

Chipotle Mexican Grill (NYSE:CMG) has significantly outperformed the market over the past 5 years, with an annualized return of 26.19%. A $1000 investment in CMG 5 years ago would now be worth $3,258.95, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 5:00 pm

AMP

Ameriprise Financial (NYSE:AMP) has significantly outperformed the market over the past 5 years, with an average annual return of 28.29%. A $100 investment in AMP 5 years ago would now be worth $345.06, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 5:00 pm

MCD

McDonald's plans a £1 billion investment to open over 200 new restaurants in the UK, creating 24,000 jobs. This expansion has led to a 9% rise in McDonald's stock in August, despite a 2% year-to-date drop.

Portfolio Pulse from Zaheer Anwari

August 22, 2024 | 4:32 pm

ELF

e.l.f. Beauty (NYSE:ELF) has significantly outperformed the market over the past 5 years, with an average annual return of 57.66%. A $1000 investment in ELF 5 years ago would now be worth $9,555.06. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:30 pm

PLD

Prologis (NYSE:PLD) has outperformed the market over the past 10 years with an average annual return of 11.9%, resulting in a $100 investment growing to $307.55. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:30 pm

ACB

CGC

TLRY

Aurora Cannabis (NASDAQ:ACB) has seen a 31% increase in international sales for the first half of 2024, driven by its acquisition of MedReleaf Australia. The company dominates 30% of Canada's medical marijuana exports and shows improved profit margins. Despite higher operating expenses, Aurora's valuation remains attractive compared to competitors like Tilray (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC).

Portfolio Pulse from Nicolás Jose Rodriguez

August 22, 2024 | 4:26 pm

ROCK

Gibraltar Industries (NASDAQ:ROCK) has outperformed the market over the past 10 years, achieving an average annual return of 15.27%. A $100 investment in ROCK 10 years ago would now be worth $415.63, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:01 pm

ESTA

Establishment Labs Holdings (NASDAQ:ESTA) has received mixed analyst ratings over the past three months, with a decrease in the average 12-month price target. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. The company faces financial challenges, including declining revenue growth, low net margins, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:01 pm

GILD

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years with an average annual return of 11.47%. A $100 investment in GILD 20 years ago would be worth $889.70 today. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 22, 2024 | 4:01 pm